// App-Quantinova.ai

1588 : Single cell analysis of AR N terminal, AR C terminal and the ARv7 splice variant in the CTCs of metastatic castration resistant prostate cancer (mCRPC) patients

Researchers

Presenter

  • James Kelvin

Principal Investigators

  • David Lu

  • Davin Packer

  • Mark Landers

  • Florence Lee

  • Dena Marrinucci

  • Ryan Dittamore

  • Howard I. Scher

  • Richard Bambury

  • Dana Rathkopf

  • Nicole Schreiber

  • Zaina Arslan

  • Natalie Prigozhina

  • David Brown

  • Rachel Krupa

  • Edward Swangren

Medical Centers

  • Epic Sciences, Inc., San Diego, CA

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved